Patents by Inventor Andrew Hayhurst

Andrew Hayhurst has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200140573
    Abstract: Methods for identifying a polypeptide of interest with desired properties, like specific binding affinity to a molecule of interest or greater stability or improved solubility, from vast numbers of variants. The polypeptides of interest can be antibodies that are selected from an antibody library.
    Type: Application
    Filed: September 11, 2019
    Publication date: May 7, 2020
    Inventor: Andrew Hayhurst
  • Publication number: 20140243234
    Abstract: The present inventions relate to the selection and production of specific proteins or peptides with desired properties. The inventions relate to the agents and methods of identifying select peptides or proteins with specific binding properties or greater enzymatic performance from vast numbers of variants.
    Type: Application
    Filed: August 3, 2012
    Publication date: August 28, 2014
    Applicant: TEXAS BIOMEDICAL RESEARCH INSTITUTE
    Inventor: Andrew Hayhurst
  • Patent number: 7871796
    Abstract: The invention overcomes the deficiencies of the prior art by providing a rapid approach for isolating binding proteins capable of binding small molecules and peptides via “display-less” library screening. In the technique, libraries of candidate binding proteins, such as antibody sequences, are expressed in soluble form in the periplasmic space of gram negative bacteria, such as Escherichia coli, and are mixed with a labeled ligand. In clones expressing recombinant polypeptides with affinity for the ligand, the concentration of the labeled ligand bound to the binding protein is increased and allows the cells to be isolated from the rest of the library. Where fluorescent labeling of the target ligand is used, cells may be isolated by fluorescence activated cell sorting (FACS). The approach is more rapid than prior art methods and avoids problems associated with the surface-expression of ligand fusion proteins employed with phage display.
    Type: Grant
    Filed: August 1, 2006
    Date of Patent: January 18, 2011
    Assignee: Board of Regents, The University of Texas System
    Inventors: Gang Chen, Andrew Hayhurst, Jeffrey G. Thomas, Brent L. Iverson, George Georgiou
  • Publication number: 20070065913
    Abstract: The invention overcomes the deficiencies of the prior art by providing a rapid approach for isolating binding proteins capable of binding small molecules and peptides via “display-less” library screening. In the technique, libraries of candidate binding proteins, such as antibody sequences, are expressed in soluble form in the periplasmic space of gram negative bacteria, such as Escherichia coli, and are mixed with a labeled ligand. In clones expressing recombinant polypeptides with affinity for the ligand, the concentration of the labeled ligand bound to the binding protein is increased and allows the cells to be isolated from the rest of the library. Where fluorescent labeling of the target ligand is used, cells may be isolated by fluorescence activated cell sorting (FACS). The approach is more rapid than prior art methods and avoids problems associated with the surface-expression of ligand fusion proteins employed with phage display.
    Type: Application
    Filed: August 1, 2006
    Publication date: March 22, 2007
    Inventors: Gang Chen, Andrew Hayhurst, Jeffrey Thomas, Brent Iverson, George Georgiou
  • Patent number: 7083945
    Abstract: The invention overcomes the deficiencies of the prior art by providing a rapid approach for isolating binding proteins capable of binding small molecules and peptides via “display-less” library screening. In the technique, libraries of candidate binding proteins, such as antibody sequences, are expressed in soluble form in the periplasmic space of gram negative bacteria, such as Escherichia coli, and are mixed with a labeled ligand. In clones expressing recombinant polypeptides with affinity for the ligand, the concentration of the labeled ligand bound to the binding protein is increased and allows the cells to be isolated from the rest of the library. Where fluorescent labeling of the target ligand is used, cells may be isolated by fluorescence activated cell sorting (FACS). The approach is more rapid than prior art methods and avoids problems associated with the surface-expression of ligand fusion proteins employed with phage display.
    Type: Grant
    Filed: October 27, 2000
    Date of Patent: August 1, 2006
    Assignee: The Board of Regents of The University of Texas System
    Inventors: Gang Chen, Andrew Hayhurst, Jeffrey G. Thomas, Brent L. Iverson, George Georgiou